Cargando…
Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in BRCA-mutated cancer
Recent studies have pointed to PARP1 trapping as a key determinant of the anticancer effects of PARP1 inhibitors (PARPi). We identified RNF114, as a PARylation-dependent, E3 ubiquitin ligase involved in DNA damage response. Upon sensing genotoxicity, RNF114 was recruited, in a PAR-dependent manner,...
Autores principales: | Li, Peng, Zhen, Yuanli, Kim, Chiho, Liu, Zhengshuai, Hao, Jianwei, Deng, Heping, Deng, Hejun, Zhou, Min, Wang, Xu-Dong, Qin, Tian, Yu, Yonghao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599614/ https://www.ncbi.nlm.nih.gov/pubmed/37878693 http://dx.doi.org/10.1126/sciadv.adg7752 |
Ejemplares similares
-
Clinical PARP inhibitors allosterically induce PARP2 retention on DNA
por: Langelier, Marie-France, et al.
Publicado: (2023) -
PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities
por: Đukić, Nina, et al.
Publicado: (2023) -
A two-step mechanism governing PARP1-DNA retention by PARP inhibitors
por: Xue, Huijun, et al.
Publicado: (2022) -
RNF114 suppresses metastasis through regulation of PARP10 in cervical cancer cells
por: Zhao, Yahui, et al.
Publicado: (2021) -
Synthetic neutrophil extracellular traps dissect bactericidal contribution of NETs under regulation of α-1-antitrypsin
por: Yang, Ting, et al.
Publicado: (2023)